Managing an unplanned gap in supply — what changed since posts 31–60
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
Adding thanks rather than a view. I do not have a view worth the space.
The arithmetic in post #33 is right; the assumption feeding it is the part to check.
The version of Managing an unplanned gap that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
I have been on both sides of the Managing an unplanned gap argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
Post #33 describes the usual case. This is about the unusual one.
What I want from this Managing an unplanned gap thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
Anyone reporting availability should say the region and the date, because both determine whether the report is usable.
Stating my assumptions rather than smuggling them in.
This is the first time the answer has come with its own limits attached. Appreciated.
This follows post #37 rather than contradicting it.
Reports that a pharmacy has stock are the least durable information on the site and are still worth posting with a date.
Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.
The number is defensible. The precision I gave it is not.
Coming back to post #40, because the follow-up matters more than the original answer.
Date any statement about supply. Positions change within weeks and the archive keeps posts permanently.
Flagging that the sources on this are thinner than the confidence in the thread suggests.
Adding the measurement that post #42 says would settle it.
Since Managing an unplanned gap keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience will review it.
Agreed, and I will stop repeating the version of this I had been repeating.
Where a manufacturer publishes a supply statement, that document is more reliable than any aggregation of individual experiences.
Answering the question post #48 raises rather than the one it answers.
Device availability and compound availability are separate supply chains and the device is frequently the constraint.
One of those cases where knowing the mechanism does not help the decision.
Where a shortage forces a gap, the pharmacokinetics mean a missed week is a perturbation rather than a reset, which is worth knowing.
Right, and stated more narrowly than I would have dared to state it.
I read post #51 twice before replying, because I had assumed the opposite.
Where an alternative within the class is available, the comparison is a clinical one and the doses are not equivalent.
I am reporting what happened, not recommending it.
Post #51 answers the question as asked. The question underneath it is different.
Two things can be true about Managing an unplanned gap at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people defending the first against attacks on the second.
Nothing here is medical advice, and decisions about what to do during a supply interruption belong with a prescriber.
This follows post #55 rather than contradicting it.
Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
Someone should write this up properly, and it should probably not be me.
Coming back to post #55, because the follow-up matters more than the original answer.
Managing an unplanned gap is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which one is being asked for.
Where a shortage forces a gap, the pharmacokinetics mean a missed week is a perturbation rather than a reset, which is worth knowing.
One more caveat and then I will stop qualifying: the sample selected itself.
Picking up post #58: that is the part I would want checked first.
Answering the Managing an unplanned gap question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first measurement was taken.